Cresco Labs Inc.
CL
CNSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.26% | -6.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.26% | -6.40% | |||
| Cost of Revenue | -7.76% | -5.18% | |||
| Gross Profit | 6.18% | -7.76% | |||
| SG&A Expenses | -11.11% | 3.72% | |||
| Depreciation & Amortization | -14.27% | -5.52% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.27% | -1.97% | |||
| Operating Income | 86.96% | -37.51% | |||
| Income Before Tax | 398.80% | -130.05% | |||
| Income Tax Expenses | 16.21% | 447.25% | |||
| Earnings from Continuing Operations | 8.80% | -3,570.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -404.36% | 116.67% | |||
| Net Income | -13.18% | -230.10% | |||
| EBIT | 86.96% | -37.51% | |||
| EBITDA | 41.90% | -25.68% | |||
| EPS Basic | -11.89% | -226.98% | |||
| Normalized Basic EPS | 1,440.00% | 114.93% | |||
| EPS Diluted | -11.89% | -226.98% | |||
| Normalized Diluted EPS | 1,440.00% | 114.93% | |||
| Average Basic Shares Outstanding | 1.16% | 0.66% | |||
| Average Diluted Shares Outstanding | 1.16% | 0.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||